Govt probes drug resistant TB cases in Mumbai
New Delhi: With a Mumbai hospital reporting the first case of total drug resistant (TDR) tuberculosis (TB) in the country, the health ministry Tuesday sent a team to Mumbai to ascertain facts about the new development.
The central team comprising senior chief medical officer, Central TB Division (CTD), consultant (Drug Resistant TB), CTD, and national programme officer (Laboratory) are in touch with the health authorities of Maharashtra, said a health ministry official.
Experts from WHO-India reached Mumbai on Monday and started an analysis of the situation. The team is also involving experts from concerned stake holders including Hinduja Hospital, Mumbai.
The P.D. Hinduja hospital detected four people with total drug resistant (TDR) tuberculosis (TB) till November last year. In the last two months, eight others have been detected with TDR-TB.
According to the health ministry, the Hinduja Hospital Laboratory is not accredited to the central government`s Revised National Tuberculosis Control Programme for diagnosis of Extensively Drug-Resistant (XDR)/Totally Drug Resistant (TDR) cases.
"It is only accredited for conducting Drug Susceptibility Testing (DST) by liquid culture and sensitivity for first-line drug only," an official said.
The Revised National TB Control Programme ((RNTCP) has accredited only three labs for conducting quality-assured second-line anti-TB drug susceptibility testing. These labs are National TB Institute (NTI), Bangalore, LRS Institute of TB and Chest Disease, New Delhi, and National Institute of Research in Tuberculosis, Chennai.
"The term TDR-TB is neither recognised by the WHO nor by RNTCP. For now, these cases are defined as Extensively Drug Resistant Tuberculosis (XDR-TB), according to WHO definitions, and accordingly can be managed by national XDR-TB treatment guidelines," the official said.
The preliminary results of second-line drug susceptibility testing for MDR-TB patients from DOTS (Directly Observed Treatment Short) and the samples collected from Gujarat and Maharashtra drug resistance survey show that there is no new cases of XDR-TB and 0.5 percent are among re-treatment cases, added the official.
Download the all new Zee News app for Android and iOS to stay up to date with latest headlines and news stories in Politics, Entertainment, Sports, Technology, Business and much more from India and around the world.
comments powered by Disqus
- Helicopter ferrying 6 pilgrims, woman pilot crashes near Katra
- Growing sense of despondency in India from last 6-8 months: Aamir Khan
- 8th Ramnath Goenka Awards: Sudhir Chaudhary awarded for Excellence in Journalism
- Arvind Kejriwal clarifies his friendly gesture with Lalu Prasad Yadav
- I am surviving only on 25% of my liver today, says Big B
- Karnataka, Madhya Pradesh bypoll results: As it happened on November 24
- Lesson for jihadi aspirants? ISIS says Indians not good enough as 6 out of 23 fighters from India are killed
- Aamir Khan feels intolerance growing in India, says his wife suggested moving out of India
- Intolerance issue: When did ‘Incredible India’ become ‘Intolerant India’, Anupam Kher asks Aamir Khan
- Boon for SC/ST candidates? Birth, caste certificates likely to be merged